BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 19897083)

  • 21. The endocannabinoid system during development: emphasis on perinatal events and delayed effects.
    Fride E; Gobshtis N; Dahan H; Weller A; Giuffrida A; Ben-Shabat S
    Vitam Horm; 2009; 81():139-58. PubMed ID: 19647111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocannabinoid-mediated control of synaptic transmission.
    Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
    Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocannabinoids in the immune system and cancer.
    Parolaro D; Massi P; Rubino T; Monti E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):319-32. PubMed ID: 12052046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid signalling in the enteric nervous system.
    Galligan JJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
    Lamontagne D; Lépicier P; Lagneux C; Bouchard JF
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):242-6. PubMed ID: 16618028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid rafts: a nexus for endocannabinoid signaling?
    McFarland MJ; Barker EL
    Life Sci; 2005 Aug; 77(14):1640-50. PubMed ID: 15978630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
    Svízenská I; Dubový P; Sulcová A
    Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiovascular effects of cannabinoids].
    Járai Z; Kúnos G
    Orv Hetil; 2002 Jun; 143(26):1563-8. PubMed ID: 12140859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocannabinoids and cannabinoid receptor genetics.
    Onaivi ES; Leonard CM; Ishiguro H; Zhang PW; Lin Z; Akinshola BE; Uhl GR
    Prog Neurobiol; 2002 Apr; 66(5):307-44. PubMed ID: 12015198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis: pharmacology and toxicology in animals and humans.
    Adams IB; Martin BR
    Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
    González S; Cebeira M; Fernández-Ruiz J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoids and prefrontal cortical function: insights from preclinical studies.
    Egerton A; Allison C; Brett RR; Pratt JA
    Neurosci Biobehav Rev; 2006; 30(5):680-95. PubMed ID: 16574226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of the endocannabinoid system in learning and memory.
    Marsicano G; Lafenêtre P
    Curr Top Behav Neurosci; 2009; 1():201-30. PubMed ID: 21104385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocannabinoid system and mood disorders: priming a target for new therapies.
    Micale V; Di Marzo V; Sulcova A; Wotjak CT; Drago F
    Pharmacol Ther; 2013 Apr; 138(1):18-37. PubMed ID: 23261685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoid System Components: Overview and Tissue Distribution.
    Joshi N; Onaivi ES
    Adv Exp Med Biol; 2019; 1162():1-12. PubMed ID: 31332731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?
    Fowler CJ; Rojo ML; Rodriguez-Gaztelumendi A
    Exp Neurol; 2010 Jul; 224(1):37-47. PubMed ID: 20353772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids: potential targets for bladder dysfunction.
    Ruggieri MR
    Handb Exp Pharmacol; 2011; (202):425-51. PubMed ID: 21290238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
    Hu G; Ren G; Shi Y
    Oncogene; 2011 Jan; 30(2):139-41. PubMed ID: 21057532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical basis of cannabis addiction.
    Maldonado R; Berrendero F; Ozaita A; Robledo P
    Neuroscience; 2011 May; 181():1-17. PubMed ID: 21334423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.